S&P 500   3,585.62
DOW   28,725.51
QQQ   267.26
Want to Increase Your Conversion Rates? This Is the Biggest Threat to Your Success.
In 20 years, this little-known trader didn’t have a single losing year… (Ad)
Russia accused of 'kidnapping' head of Ukraine nuclear plant
EU chief: New Greece-Bulgaria gas pipeline 'means freedom'
In 20 years, this little-known trader didn’t have a single losing year… (Ad)
Danish Energy Agency says Nord Stream 2 gas pipeline under Baltic Sea appears to have stopped leaking gas
UK train strikes and energy hikes add to a week of turmoil
In 20 years, this little-known trader didn’t have a single losing year… (Ad)
Russia blindfolds, detains Ukraine nuclear plant chief
NIH to fund unproven ALS drugs under patient-backed law
S&P 500   3,585.62
DOW   28,725.51
QQQ   267.26
Want to Increase Your Conversion Rates? This Is the Biggest Threat to Your Success.
In 20 years, this little-known trader didn’t have a single losing year… (Ad)
Russia accused of 'kidnapping' head of Ukraine nuclear plant
EU chief: New Greece-Bulgaria gas pipeline 'means freedom'
In 20 years, this little-known trader didn’t have a single losing year… (Ad)
Danish Energy Agency says Nord Stream 2 gas pipeline under Baltic Sea appears to have stopped leaking gas
UK train strikes and energy hikes add to a week of turmoil
In 20 years, this little-known trader didn’t have a single losing year… (Ad)
Russia blindfolds, detains Ukraine nuclear plant chief
NIH to fund unproven ALS drugs under patient-backed law
S&P 500   3,585.62
DOW   28,725.51
QQQ   267.26
Want to Increase Your Conversion Rates? This Is the Biggest Threat to Your Success.
In 20 years, this little-known trader didn’t have a single losing year… (Ad)
Russia accused of 'kidnapping' head of Ukraine nuclear plant
EU chief: New Greece-Bulgaria gas pipeline 'means freedom'
In 20 years, this little-known trader didn’t have a single losing year… (Ad)
Danish Energy Agency says Nord Stream 2 gas pipeline under Baltic Sea appears to have stopped leaking gas
UK train strikes and energy hikes add to a week of turmoil
In 20 years, this little-known trader didn’t have a single losing year… (Ad)
Russia blindfolds, detains Ukraine nuclear plant chief
NIH to fund unproven ALS drugs under patient-backed law
S&P 500   3,585.62
DOW   28,725.51
QQQ   267.26
Want to Increase Your Conversion Rates? This Is the Biggest Threat to Your Success.
In 20 years, this little-known trader didn’t have a single losing year… (Ad)
Russia accused of 'kidnapping' head of Ukraine nuclear plant
EU chief: New Greece-Bulgaria gas pipeline 'means freedom'
In 20 years, this little-known trader didn’t have a single losing year… (Ad)
Danish Energy Agency says Nord Stream 2 gas pipeline under Baltic Sea appears to have stopped leaking gas
UK train strikes and energy hikes add to a week of turmoil
In 20 years, this little-known trader didn’t have a single losing year… (Ad)
Russia blindfolds, detains Ukraine nuclear plant chief
NIH to fund unproven ALS drugs under patient-backed law
NYSE:PFE

Pfizer - PFE News Today

$43.76
-0.40 (-0.91%)
(As of 09/30/2022 12:00 AM ET)
Add
Compare
Today's Range
$43.73
$44.61
50-Day Range
$43.76
$52.30
52-Week Range
$40.94
$61.71
Volume
22.96 million shs
Average Volume
16.69 million shs
Market Capitalization
$245.60 billion
P/E Ratio
8.56
Dividend Yield
3.62%
Price Target
$57.00
Get Pfizer News Delivered to You Automatically

Sign up to receive the latest news and ratings for PFE and its competitors with MarketBeat's FREE daily newsletter.



PFE Media Mentions By Week

PFE Media Sentiment

Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press.

PFE
News Sentiment

0.21

0.83

Average
Medical
News Sentiment

PFE News Coverage

We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week.

PFE Articles
This Week

15

28

PFE Articles
Average Week

SourceHeadline
marketbeat.com logoPfizer Inc. (NYSE:PFE) Given Average Recommendation of "Moderate Buy" by Brokerages
marketbeat.com - October 1 at 2:22 AM
marketbeat.com logoNovavax Remains a Risk-On Stock in a Risk-Off Market (PFE)
marketbeat.com - September 21 at 3:35 PM
marketbeat.com logoAre Medtronic And Intuitive Surgical Poised For Big Growth? (PFE)
marketbeat.com - August 9 at 10:27 AM
marketbeat.com logo3 Pharma Stocks' Post-Earnings Price Moves (PFE)
marketbeat.com - August 3 at 3:00 PM
marketbeat.com logo3 Health Care Stocks in Great Financial Health (PFE)
marketbeat.com - August 2 at 11:46 AM
benzinga.com logoWhat Are Whales Doing With Pfizer - Pfizer (NYSE:PFE) - Benzinga
benzinga.com - September 30 at 8:08 PM
finance.yahoo.com logoPfizer (PFE), BNTX Seek EU Nod for Omicron Booster in Kids
finance.yahoo.com - September 29 at 2:05 PM
finance.yahoo.com logoPfizer Inc.'s (NYSE:PFE) Earnings Are Not Doing Enough For Some Investors
finance.yahoo.com - September 29 at 8:00 AM
marketwatch.com logoPfizer Inc. stock rises Wednesday, still underperforms market - MarketWatch
marketwatch.com - September 29 at 2:21 AM
finance.yahoo.com logoDelix Therapeutics and Pfizer UK Recognized as Gender Equity Champions for Women in the Workplace by Healthcare Businesswomen's Association - Yahoo Finance
finance.yahoo.com - September 28 at 1:20 AM
msn.com logoPfizer Inc, BioNTech seek FDA approval for Omicron-centric vaccine booster for children
msn.com - September 27 at 8:10 PM
markets.businessinsider.com logoProstate Cancer Therapy Market Expands; Pfizer, Lantheus Stocks Look Healthy
markets.businessinsider.com - September 27 at 8:10 PM
finance.yahoo.com logoPfizer (PFE) Seeks FDA Approval for Omicron Booster in Kids
finance.yahoo.com - September 27 at 3:10 PM
finance.yahoo.com logoPfizer (PFE) Stock Moves -0.57%: What You Should Know
finance.yahoo.com - September 26 at 11:51 PM
nasdaq.com logoPfizer seeks FDA nod for Omicron-retooled booster for kids aged 5-11 yrs
nasdaq.com - September 26 at 1:50 PM
reuters.com logoPfizer/BioNTech seek FDA nod for new COVID boosters for children
reuters.com - September 26 at 1:50 PM
nasdaq.com logoPfizer, BioNTech Apply For EUA In US Of Omicron BA.4/BA.5-Adapted Bivalent Vaccine Booster In Kids
nasdaq.com - September 26 at 1:50 PM
msn.com logoPfizer and BioNTech seek authorization of omicron-targeted booster for children aged 5 to 11
msn.com - September 26 at 1:50 PM
finance.yahoo.com logoLittle Excitement Around Pfizer Inc.'s (NYSE:PFE) Earnings
finance.yahoo.com - September 25 at 9:31 AM
reuters.com logoPfizer CEO tests positive for COVID for a second time - Reuters
reuters.com - September 24 at 8:08 PM
wsj.com logoCovid-19 Vaccine Rollout Carries Lessons for Pharma Supply Chains, Says Pfizer Executive - The Wall Street Journal
wsj.com - September 24 at 10:07 AM
markets.businessinsider.com logoPfizer To Supply 6 Mln Paxlovid Treatment Courses To Fight Covid-19
markets.businessinsider.com - September 24 at 12:06 AM
nasdaq.com logoAre Pfizer Inc.'s (NYSE:PFE) Fundamentals Good Enough to Warrant Buying Given The Stock's Recent Weakness?
nasdaq.com - September 24 at 12:06 AM
businessinsider.com logoA Pfizer leader reveals the company's innovation plans around mRNA - Business Insider
businessinsider.com - September 23 at 7:05 PM
latimes.com logoModerna vs Pfizer: Is it OK to mix and match the updated COVID-19 booster shots? - Los Angeles Times
latimes.com - September 23 at 2:05 PM
usatoday.com logoFact check: Misinterpretation leads to false claim about Pfizer's COVID-19 vaccine and pregnancy - USA TODAY
usatoday.com - September 23 at 9:05 AM
reuters.com logoU.S. cutting global donations of Pfizer COVID shots as demand slows - Reuters
reuters.com - September 23 at 9:05 AM
MarketBeat logoPfizer Inc. Announces Quarterly Dividend of $0.40 (NYSE:PFE)
americanbankingnews.com - September 23 at 7:52 AM
bloomberg.com logoPfizer, US Revise Donated-Vaccine Contract as World Demand Plummets - Bloomberg
bloomberg.com - September 22 at 5:16 PM
reuters.com logoPfizer applies to Swissmedic for authorisation of another COVID-19 vaccine - Reuters
reuters.com - September 22 at 10:31 AM
reuters.com logoPfizer to supply up to 6 mln COVID pill courses for lower income countries - Reuters
reuters.com - September 22 at 10:31 AM
finance.yahoo.com logoPfizer to Supply Global Fund Up to 6 Million PAXLOVID™ Treatment Courses for Low-and-Middle-Income Countries
finance.yahoo.com - September 22 at 10:31 AM
finance.yahoo.com logoPfizer Declares Fourth-Quarter 2022 Dividend
finance.yahoo.com - September 22 at 10:31 AM
benzinga.com logoThis Is What Whales Are Betting On Pfizer - Pfizer (NYSE:PFE) - Benzinga
benzinga.com - September 22 at 12:30 AM
businesswire.com logoPfizer Invites Public to View and Listen to Webcast of November 1 Conference Call with Analysts - Business Wire
businesswire.com - September 21 at 7:30 PM
finance.yahoo.com logoPfizer Inc.'s (NYSE:PFE) Fundamentals Look Pretty Strong: Could The Market Be Wrong About The Stock?
finance.yahoo.com - September 21 at 9:06 AM
seekingalpha.com logoPfizer: Do Not Underestimate The Paxlovid Revenues
seekingalpha.com - September 21 at 1:02 AM
fool.com logoCan This Tiny Biotech Take On Pfizer? - The Motley Fool
fool.com - September 20 at 4:54 PM
barrons.com logoHaleon Won't Indemnify Pfizer, GSK Over Zantac - Barron's
barrons.com - September 20 at 4:54 PM
fool.com logoCould This Be Pfizer's Next Billion-Dollar Vaccine? - The Motley Fool
fool.com - September 20 at 4:54 PM
reuters.com logoHaleon rejects Zantac indemnification requests from GSK, Pfizer - Reuters
reuters.com - September 20 at 3:16 AM
wsj.com logoAmazon, Pfizer Among Companies Pledging to Hire 20000 Refugees - The Wall Street Journal
wsj.com - September 19 at 5:15 PM
seekingalpha.com logoPfizer Stock As A Recession Play (NYSE:PFE) - Seeking Alpha
seekingalpha.com - September 19 at 5:15 PM
benzinga.com logoAfter US Study, Pfizer's 20-Valent Pneumococcal Jab Aces European Infant Study
benzinga.com - September 19 at 12:47 PM
reuters.com logoBrazil approves Pfizer vaccine for children as young as six months - Reuters.com
reuters.com - September 17 at 5:44 PM
nasdaq.com logoIs Trending Stock Pfizer Inc. (PFE) a Buy Now? - Nasdaq
nasdaq.com - September 17 at 2:42 AM
finance.yahoo.com logo2 Good-News Stocks on a Frightful Friday
finance.yahoo.com - September 16 at 9:42 PM
finance.yahoo.com logoPfizer's (PFE) Late-Stage Meningococcal Jab Study Meets Goal
finance.yahoo.com - September 16 at 4:35 PM
apnews.com logoStudy finds Pfizer vaccine boosts, not destroys, immunity from past COVID-19 infection - The Associated Press - en Español
apnews.com - September 16 at 1:20 AM
reuters.com logoLawsuit claims Pfizer fellowship program is biased against whites, Asian-Americans - Reuters
reuters.com - September 15 at 8:20 PM
marketwatch.com logoPfizer's Five-Way Meningococcal Vaccine Hits Phase 3 Goals >PFE - MarketWatch
marketwatch.com - September 15 at 3:20 PM
investors.com logoVaccine Stocks: Will Updated Boosters Stoke Demand For Pfizer, Moderna? | Investor's Business Daily - Investor's Business Daily
investors.com - September 15 at 3:20 PM
finance.yahoo.com logoPfizer's Pentavalent Meningococcal Vaccine Candidate Shows Efficacy In Adolescents
finance.yahoo.com - September 15 at 3:20 PM
bloomberg.com logoPfizer Shot Fights Five Types of Meningitis Bacteria in Successful Trial - Bloomberg
bloomberg.com - September 15 at 10:19 AM
finance.yahoo.com logoPfizer Announces Positive Top-Line Results from Phase 3 Trial of Pentavalent Meningococcal Vaccine Candidate (MenABCWY) in Adolescents
finance.yahoo.com - September 15 at 10:19 AM
Get Pfizer News Delivered to You Automatically

Sign up to receive the latest news and ratings for PFE and its competitors with MarketBeat's FREE daily newsletter.

This page (NYSE:PFE) was last updated on 10/2/2022 by MarketBeat.com Staff

MarketBeat Resources

Premium Research Tools

MarketBeat All Access subscribers can access stock screeners, the Idea Engine, data export tools, research reports, and other premium tools.

Discover All Access

Market Data and Calendars

Looking for new stock ideas? Want to see which stocks are moving? View our full suite of financial calendars and market data tables, all for free.

View Market Data

Investing Education and Resources

Receive a free world-class investing education from MarketBeat. Learn about financial terms, types of investments, trading strategies and more.

Financial Terms
Details Here
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more about MarketBeat.

MarketBeat is accredited by the Better Business Bureau MarketBeat is rated as Great on TrustPilot

© American Consumer News, LLC dba MarketBeat® 2010-2022. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | contact@marketbeat.com | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security.

Our Accessibility Statement | Terms of Service | Privacy Policy | Do Not Sell My Information | RSS Feeds

© 2022 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see Barchart's disclaimer.